Status:
COMPLETED
Effect of Rosuvastatin in Intracerebral Hemorrhage
Lead Sponsor:
Universidad Autonoma de San Luis Potosí
Conditions:
Intracerebral Hemorrhage
Stroke
Eligibility:
All Genders
16-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether rosuvastatin is effective in the management of acute phase of intracerebral hemorrhage and if it impact outcome by NIHSS.
Detailed Description
The intracerebral hemorrhage (ICH) is a frequent problem of health, with high morbid-mortality. In addition it originates expensive expenses in health care systems. ICH produces damage by mass effect...
Eligibility Criteria
Inclusion
- Men or Women \>16 and \< 80 years with ICH and hospital attention in less 24 hours
- Confirmation by CT scan
- Acceptance by family
Exclusion
- History of stroke
- History of neurological disease, head injury o psychiatric disorder with disability
- Glasgow less than 9
- Administration 24 hours before: fibrates, niacin, ciclosporin, azoles, macrolides, inhibitors of protease, nefazodone, verapamil, diltiazem, amiodarone.
- Use before hospital of: mannitol, barbiturates, corticosteroids, calcium antagonists
- Any lesion which needs surgery
- Allergy to drug used
- cerebral death
- Hepatic disease (Child B y C) or myopathy (or) history
- Management in other Hospital
- Pregnancy
- ICH major than 60 ml.
- hypothyroidism
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00364559
Start Date
August 1 2006
End Date
December 1 2006
Last Update
March 26 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Central "Dr. Ignacio Morones Prieto"
San Luis Potosí City, San Luis Potosí, Mexico, 78240